Bottom line
How much do FBIOX and FBTAX overlap?
52% of their top holdings overlap by weight. 13 securities appear in both funds' top 25, making up 40.4% of FBIOX's assets and 49.4% of FBTAX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings FBIOX and FBTAX have in common
| Holding | % of FBIOX | % of FBTAX | Overlap |
|---|---|---|---|
| Abbvie Inc | 9.22% | 14.71% | 9.22% |
| Amgen Inc | 6.53% | 2.37% | 2.37% |
| Gilead Sciences Inc | 4.82% | 5.70% | 4.82% |
| Fidelity Revere Street Trust | 3.35% | 1.96% | 1.96% |
| Alnylam Pharmaceuticals Inc | 2.93% | 3.62% | 2.93% |
| Insmed Inc | 2.25% | 3.05% | 2.25% |
| Argenx Se | 2.25% | 3.00% | 2.25% |
| Ascendis Pharma A/s | 2.04% | 2.99% | 2.04% |
| Revolution Medicines Inc | 2.02% | 3.00% | 2.02% |
| Natera Inc | 1.41% | 1.43% | 1.41% |
| Moderna Inc | 1.28% | 1.60% | 1.28% |
| Biogen Inc | 1.26% | 2.71% | 1.26% |
| Cogent Biosciences Inc | 1.07% | 3.25% | 1.07% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FBIOX
- Krystal Biotech Inc — 10.58%
- Praxis Precision Medicines Inc. — 2.47%
- Ucb Sa — 2.00%
- Jazz Pharmaceuticals Plc — 1.84%
- Scholar Rock Holding Corp — 1.55%
- Axsome Therapeutics Inc — 1.28%
- Protagonist Therapeutics Inc — 1.15%
- Roivant Sciences Ltd — 1.13%
- Tango Therapeutics Inc — 0.98%
- Celcuity Inc — 0.95%
- Madrigal Pharmaceuticals Inc — 0.93%
- Bridgebio Pharma Inc — 0.89%
Only in FBTAX
- Spyre Therapeutics Inc — 3.83%
- Dianthus Therapeutics Inc — 3.55%
- Oruka Therapeutics Inc — 3.24%
- Mbx Biosciences Inc — 2.45%
- Amylyx Pharmaceuticals Inc — 2.25%
- Vaxcyte Inc — 1.97%
- Relay Therapeutics Inc — 1.58%
- Viridian Therapeutics Inc — 1.53%
- Kiniksa Pharmaceuticals International Plc — 1.41%
- Vertex Pharmaceuticals Inc — 1.39%
- Enliven Therapeutics Inc — 1.25%
- Alumis Inc — 1.22%
Asset mix
| Asset type | FBIOX | FBTAX |
|---|---|---|
| Stocks | 99.0% | 98.2% |
| Cash & short-term funds | 3.5% | 2.4% |
| Preferred stock | 0.9% | 1.5% |
| Bonds | — | 0.1% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)
Country mix
| Country | FBIOX | FBTAX |
|---|---|---|
| US | 88.5% | 87.8% |
| NL | 2.9% | 4.3% |
| DK | 2.6% | 3.0% |
| BE | 2.0% | 0.4% |
| IE | 2.0% | — |
| KY | 0.6% | 1.8% |
| GB | 0.8% | 1.8% |
| CA | 0.4% | 1.4% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do FBIOX and FBTAX overlap?
What stocks do FBIOX and FBTAX have in common?
Should I own both FBIOX and FBTAX?
Which holds more stocks, FBIOX or FBTAX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.